Insider Selling: Palomar (NASDAQ:PLMR) CEO Sells 5,000 Shares of Stock

Palomar Holdings, Inc. (NASDAQ:PLMR) CEO Mac Armstrong sold 5,000 shares of the company’s stock in a transaction on Thursday, February 12th. The stock was sold at an average price of $122.60, for a total transaction of $613,000.00. Following the completion of the sale, the chief executive officer owned 343,388 shares of the company’s stock, valued at $42,099,368.80. This represents a 1.44% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website.

Mac Armstrong also recently made the following trade(s):

• On Saturday, January 31st, Mac Armstrong sold 2,205 shares of Palomar stock. The stock was sold at an average price of $121.74, for a total value of $268,436.70.
• On Saturday, January 31st, Mac Armstrong sold 2,205 shares of Palomar stock. The shares were sold at an average price of $121.74, for a total value of $268,436.70.
• On Thursday, January 29th, Mac Armstrong sold 5,399 shares of Palomar stock. The shares were sold at an average price of $122.04, for a total value of $658,893.96.
• On Thursday, January 29th, Mac Armstrong sold 5,399 shares of Palomar stock. The stock was sold at an average price of $122.04, for a total value of $658,893.96.
• On Wednesday, January 28th, Mac Armstrong sold 11,484 shares of Palomar stock. The shares were sold at an average price of $119.88, for a total transaction of $1,376,701.92.
• On Wednesday, January 21st, Mac Armstrong sold 5,000 shares of Palomar stock. The stock was sold at an average price of $129.00, for a total transaction of $645,000.00.
• On Thursday, January 15th, Mac Armstrong sold 2,310 shares of Palomar stock. The shares were sold at an average price of $130.00, for a total transaction of $300,300.00.
• On Friday, November 21st, Mac Armstrong sold 5,000 shares of Palomar stock. The stock was sold at an average price of $122.86, for a total transaction of $614,300.00.

Palomar Stock Up 4.0%

PLMR stock traded up $5.09 during mid-day trading on Friday, reaching $132.10. 455,917 shares of the stock traded hands, compared to its average volume of 258,007. The firm has a market capitalization of $3.50 billion, a PE ratio of 18.40 and a beta of 0.44. The business has a 50-day moving average of $128.42 and a two-hundred day moving average of $123.23. Palomar Holdings, Inc. has a 52 week low of $107.75 and a 52 week high of $175.85.

Palomar (NASDAQ:PLMR) last announced its earnings results on Wednesday, February 11th. The company reported $2.24 earnings per share for the quarter, beating the consensus estimate of $2.06 by $0.18. The firm had revenue of $492.63 million during the quarter, compared to the consensus estimate of $204.58 million. Palomar had a return on equity of 23.48% and a net margin of 22.50%.The firm’s revenue for the quarter was up 62.7% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.52 EPS. On average, equities research analysts anticipate that Palomar Holdings, Inc. will post 5.99 EPS for the current fiscal year.

Key Palomar News

Here are the key news stories impacting Palomar this week:

• Positive Sentiment: Q4 earnings and revenue beat consensus, driven by higher premiums and underwriting gains; management also raised its 2026 outlook — a primary driver of the stock’s strength. Palomar Q4 Earnings & Revenues Beat Estimates, Premiums Rise Y/Y
• Positive Sentiment: Brokerage coverage remains constructive — the consensus recommendation is around “Moderate Buy,” which supports continued investor interest. Palomar Given Average Recommendation of “Moderate Buy” by Brokerages
• Neutral Sentiment: Analyst/press deep-dive notes that Palomar’s diversification is driving top-line growth, but highlights emerging questions about margins and underwriting mix — watch margin trends in upcoming quarters. PLMR Q4 deep dive: Diversification drives growth, margin questions emerge
• Neutral Sentiment: Full Q4 earnings call transcript is available for detail on management’s commentary and guidance assumptions — useful for investors modeling forward earnings and loss ratios. Palomar Q4 2025 Earnings Call Transcript
• Negative Sentiment: Insider sale: CEO Mac Armstrong sold 5,000 shares at ~$122.60 (filed with the SEC), trimming his stake by ~1.44% — a potential sentiment headwind even though his remaining holding remains large. SEC Filing: Insider Sale

Hedge Funds Weigh In On Palomar

Large investors have recently modified their holdings of the business. Wealth Enhancement Advisory Services LLC increased its stake in shares of Palomar by 3.3% during the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 2,546 shares of the company’s stock worth $333,000 after purchasing an additional 82 shares during the last quarter. Quadrant Capital Group LLC increased its position in Palomar by 2.0% during the fourth quarter. Quadrant Capital Group LLC now owns 4,464 shares of the company’s stock worth $602,000 after buying an additional 88 shares during the last quarter. Clearstead Advisors LLC raised its stake in Palomar by 31.0% in the third quarter. Clearstead Advisors LLC now owns 397 shares of the company’s stock valued at $46,000 after buying an additional 94 shares during the period. California State Teachers Retirement System lifted its position in shares of Palomar by 0.4% in the second quarter. California State Teachers Retirement System now owns 24,207 shares of the company’s stock valued at $3,734,000 after buying an additional 97 shares during the last quarter. Finally, Bank of Montreal Can lifted its position in shares of Palomar by 1.7% in the second quarter. Bank of Montreal Can now owns 5,766 shares of the company’s stock valued at $889,000 after buying an additional 98 shares during the last quarter. 90.25% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of equities research analysts recently issued reports on the stock. Evercore ISI started coverage on shares of Palomar in a research report on Monday. They set an “outperform” rating and a $150.00 target price for the company. Wall Street Zen cut shares of Palomar from a “buy” rating to a “hold” rating in a research note on Saturday, February 7th. Weiss Ratings upgraded Palomar from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Wednesday, January 14th. Keefe, Bruyette & Woods lifted their price target on shares of Palomar from $170.00 to $171.00 and gave the stock an “outperform” rating in a research report on Tuesday, January 6th. Finally, JPMorgan Chase & Co. boosted their price objective on Palomar from $145.00 to $155.00 and gave the company an “overweight” rating in a research report on Wednesday, January 7th. Seven research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. According to MarketBeat, Palomar presently has a consensus rating of “Moderate Buy” and an average price target of $158.14.

About Palomar

Palomar Holdings, Inc (NASDAQ: PLMR) is a specialty insurance holding company focused on providing medical stop-loss coverage and related administrative services to self-funded employer health plans in the United States. The firm operates through two primary business segments—Medical Stop-Loss and Specialty Program Management—to deliver tailored risk protection and comprehensive program administration.

In its Medical Stop-Loss segment, Palomar underwrites excess and aggregate stop-loss policies designed to shield self-insured employers from catastrophic medical claims that exceed pre-determined retention levels.